Essex Bio-Technology Limited (1061.HK)
HKD 2.76
(0.37%)
HKD 2.76
(0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.7 Billion | 1.31 Billion | 1.63 Billion | 978.11 Million | 1.27 Billion | 1.17 Billion |
| Cost of Revenue | 167.26 Million | 128.38 Million | 241.89 Million | 184.28 Million | 246.12 Million | 202.91 Million |
| Gross Profit | 1.53 Billion | 1.18 Billion | 1.39 Billion | 793.82 Million | 1.03 Billion | 973.54 Million |
| Operating Expenses | 1.22 Billion | 907.87 Million | 982.88 Million | 573.66 Million | 704.33 Million | 713.39 Million |
| Selling, General and Administrative Expenses | 1.18 Billion | 914.18 Million | 989.71 Million | 588.24 Million | 714.54 Million | 718.62 Million |
| Research and Development Expenses | 39.14 Million | 23.5 Million | 23.52 Million | 8.57 Million | 3.4 Million | 18.12 Million |
| Other Expenses | - | -6.31 Million | -6.82 Million | -14.57 Million | -10.2 Million | -5.23 Million |
| Cost and Expenses | 1.39 Billion | 1.03 Billion | 1.22 Billion | 757.95 Million | 950.46 Million | 916.31 Million |
| Operating Income | 310.32 Million | 278.05 Million | 435.57 Million | 237.39 Million | 343.34 Million | 265 Million |
| Interest Expense | 11.21 Million | 11.47 Million | 9.22 Million | 1.42 Million | 6.96 Million | 7.4 Million |
| Income Tax Expense | 70.75 Million | 34.93 Million | 48.48 Million | 31.92 Million | 49.26 Million | 41.96 Million |
| Earnings before Tax | 347.65 Million | 260.34 Million | 394.45 Million | 250.85 Million | 351.76 Million | 273.05 Million |
| Net Income | 275.25 Million | 225.41 Million | 345.96 Million | 218.92 Million | 302.5 Million | 231.09 Million |
| Earnings Per Share Basic | 0.49 | 0.39 | 0.60 | 0.38 | 0.52 | 0.39 |
| Earnings Per Share Diluted | 0.47 | 0.38 | 0.58 | 0.37 | 0.51 | 0.38 |
| Weighted Average Shares Outstanding | 570.22 Million | 573.96 Million | 576.58 Million | 577.86 Million | 578.56 Million | 585.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 595.64 Million | 599.38 Million | 602 Million | 603.29 Million | 604.03 Million | 601.36 Million |
| Gross Margin | 0.90 | 0.90 | 0.85 | 0.81 | 0.81 | 0.83 |
| EBIT Margin | 0.25 | 0.24 | 0.29 | 0.27 | 0.29 | 0.24 |
| Profit Margin | 0.16 | 0.17 | 0.21 | 0.22 | 0.24 | 0.20 |
| EBITDA | 418.37 Million | 313.53 Million | 436.65 Million | 279.5 Million | 386.14 Million | 299.86 Million |
| Earnings Before Tax Margin | 0.18 | 0.21 | 0.27 | 0.24 | 0.27 | 0.23 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 811.63 Million | 807.19 Million | 1.7 Billion | 899.35 Million | 1.31 Billion | 661.88 Million |
| Cost of Revenue | 87.01 Million | 78.36 Million | 167.26 Million | 88.89 Million | 128.38 Million | 59.2 Million |
| Gross Profit | 724.61 Million | 728.83 Million | 1.53 Billion | 810.46 Million | 1.18 Billion | 602.68 Million |
| Operating Expenses | 568.06 Million | 600.89 Million | 1.22 Billion | 621.94 Million | 907.87 Million | 474.72 Million |
| Selling, General and Administrative Expenses | 553.18 Million | 582 Million | - | 601.69 Million | - | 462.82 Million |
| Research and Development Expenses | 14.88 Million | 18.89 Million | - | 20.25 Million | - | 11.9 Million |
| Other Expenses | - | - | 27.17 Million | - | -6.31 Million | - |
| Cost and Expenses | 655.08 Million | 679.26 Million | 1.39 Billion | 710.83 Million | 1.03 Billion | 533.93 Million |
| Operating Income | 156.54 Million | 127.93 Million | 310.32 Million | 188.52 Million | 278.05 Million | 127.95 Million |
| Interest Expense | 3.44 Million | 1.77 Million | 11.21 Million | 12.71 Million | 11.47 Million | 22.46 Million |
| Income Tax Expense | 39.94 Million | 35.71 Million | 70.75 Million | 35.04 Million | 34.93 Million | 11.46 Million |
| Earnings before Tax | 197.38 Million | 142.22 Million | 347.65 Million | 205.43 Million | 260.34 Million | 97.83 Million |
| Net Income | 157.44 Million | 105.44 Million | 275.25 Million | 169.81 Million | 225.41 Million | 86.18 Million |
| Earnings Per Share Basic | 0.28 | 0.19 | - | 0.30 | - | 0.15 |
| Earnings Per Share Diluted | 0.27 | 0.18 | - | 0.28 | - | 0.15 |
| Weighted Average Shares Outstanding | 585.22 Million | 567.58 Million | 570.22 Million | 571.3 Million | 573.96 Million | 572.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 592.97 Million | 593.92 Million | 595.64 Million | 596.73 Million | 599.38 Million | 597.66 Million |
| Gross Margin | 0.89 | 0.90 | 0.90 | 0.90 | 0.90 | 0.91 |
| EBIT Margin | 0.25 | 0.19 | - | 0.24 | - | 0.23 |
| Profit Margin | 0.19 | 0.13 | 0.16 | 0.19 | 0.17 | 0.13 |
| EBITDA | 200.27 Million | 156.41 Million | - | 219.54 Million | - | 149.18 Million |
| Earnings Before Tax Margin | 0.19 | 0.16 | 0.18 | 0.21 | 0.21 | 0.19 |
MUR
ZTLLF
TBR
CUSI
TEM
KENNAMET